PF-06446846
| CAS No. | 1632250-49-7 | Cat. No. | BCP43978 |
| Name | PF-06446846 | ||
| Synonyms | PF 06446846; PF06446846; PF-6446846; PF 6446846; PF6446846; | ||
| Formula | C22H20ClN7O | M. Wt | 433.89 |
| Description | PF-06446846 is a selective orally active PCSK9 inhibitor that appears to act by causing the ribosome to stall when synthesizing PCSK9. PCSK9 binds to the LDL receptor, preventing it from removing LDL cholesterol from the blood. PF-06446846 was found to reduce plasma PCSK9 and total cholesterol levels in rats. | ||
| Related Products | 1632250-50-0（PF-06446846 hydrochloride） | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Serine Protease | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.